Wrinkles Schminkles founder Gabrielle Requena created the kit after seeing the two women closest to her, her mother and sister, undergo cancer treatment.
“This gave me a strong desire to contribute and make a difference,” she said.
The Chest Revival Kit, which contains a Wrinkles Schminkles Chest Silicone Pad, Morning After Glow Serum and Cleaning Solution, are “100 percent safe” for women recovering from cancer treatments such as radiation and surgery.
According to Requena, the 100 percent Medical Grade Silicone pads are “scientifically proven to stimulate collagen, prevent and correct wrinkles and also improve scar healing safely”.
She said the pads will help women who have had breast cancer treatments to “revitalise their delicate décolletage”
Sydney-based dermatologist Dr Natasha Cook is also a strong believer in the power of the pads to treat women’s skin post-cancer treatment.
“As a dermatologist, I know that breast cancer and radiation therapy has a significant impact on the skin, leading to sensitivity, irritation and degradation of the breast and chest tissue.
“Medical grade silicone can assist in protecting, improving the texture and reducing sensitivity that these women suffer from.
“At Darlinghurst Dermatology we specialise in treating the chest area with combination laser therapy to combat these issues. We now routinely use these TGA-approved medical grade silicone sheets as ongoing care for the décolletage skin.”
Pink Hope founder Krystal Barter said the foundation is excited to partner with Wrinkles Schminkles and provide “our community with real products to help them during times when their skin is at its most vulnerable”.
“We wanted to provide women in our community with products that will help them heal and rejuvenate their skin after surgery and cancer treatments.”
The Limited Edition Kit will be available for $99.95 from March 1 with 100 percent of profits during the month donated to Pink Hope.
Pink Hope will use the proceeds to help drive its efforts to “provide all Australians with the necessary tools to reduce their risk of breast and ovarian cancer”.